AMS — Advanced Medical Solutions Share Price
Last trade - 00:00- £398.21m
- £468.48m
- £177.52m
- 76
- 21
- 33
- 35
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 14.4 | ||
| PEG Ratio (f) | 0.7 | ||
| EPS Growth (f) | 26.1% | ||
| Dividend Yield (f) | 1.71% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.65 | ||
| Price to Tang. Book | 15.33 | ||
| Price to Free Cashflow | 37.06 | ||
| Price to Sales | 2.24 | ||
| EV to EBITDA | 17.02 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 3.26% | ||
| Return on Equity | 2.93% | ||
| Operating Margin | 6.32% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 86.8 | 108.6 | 124.33 | 126.21 | 177.52 | 229.12 | 244.22 | 11.64% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -53.14 | +87.69 | +16.11 | -22.06 | +26.43 | +32.64 | +14.53 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Advanced Medical Solutions Group plc is a United Kingdom-based independent developer and manufacturer of tissue-healing technology, focused on quality outcomes for patients. Its surgical products, including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, Peters Surgical, Ifabond, Vitalitec and Seal-G. It also supplies wound care dressings, such as silver alginates, alginates and foams through its ActivHeal brand, and under white label. Its Surgical Business Unit includes tissue adhesives, sutures, biosurgical devices and internal fixation devices. The Woundcare Business Unit comprises a multi-product portfolio of advanced wound care dressings and a portfolio of specialist medical bulk materials and multi-layer wound care products. Its products are manufactured in the United Kingdom, Germany, France, the Netherlands, Thailand, India, the Czech Republic and Israel.
Directors
- Peter Allen NEC
- Andrew Meredith CEO
- Eddie Johnson CFO
- Alan Richardson COO
- Chris Locke CTO
- Cathy Tomlinson DHR
- Simon Coates OTH
- Rose Guang OTH
- Ross McDonald OTH
- Pieter Van-Hoof OTH
- Becky Walmsley OTH
- Owen Bromley SEC
- Grahame Cook NID (63)
- Penelope Freer NID
- Douglas Le Fort NID
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- November 1st, 1993
- Public Since
- April 30th, 2002
- No. of Employees
- 1,500
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- London Stock Exchange
- Shares in Issue
- 218,079,861
- Address
- Premier Park, 33 Road One, WINSFORD, CW7 3RT
- Web
- https://www.admedsol.com/
- Phone
- +44 1606863500
- Auditors
- Deloitte LLP
Latest News for AMS
Upcoming Events for AMS
Dividend For AMSU.L - 1.8300 GBX
Half Year 2025 Advanced Medical Solutions Group PLC Earnings Release
Similar to AMS
Abingdon Health
London Stock Exchange
Angle
London Stock Exchange
Aoti
London Stock Exchange
Aptamer
London Stock Exchange
Belluscura
London Stock Exchange
FAQ
As of Today at 19:05 UTC, shares in Advanced Medical Solutions are trading at 182.60p. This share price information is delayed by 15 minutes.
Shares in Advanced Medical Solutions last closed at 182.60p and the price had moved by -0.76% over the past 365 days. In terms of relative price strength the Advanced Medical Solutions share price has underperformed the FTSE All Share Index by -4.66% over the past year.
The overall consensus recommendation for Advanced Medical Solutions is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Advanced Medical Solutions dividend yield is 1.42% based on the trailing twelve month period.
Last year, Advanced Medical Solutions paid a total dividend of £0.03, and it currently has a trailing dividend yield of 1.42%.Looking ahead, shares in Advanced Medical Solutions are due to go ex-dividend on 2025-05-29 and the next dividend pay date is 2025-06-20.
Advanced Medical Solutions are due to go ex-dividend on 2025-05-29 and the next dividend pay date is 2025-06-20. The historic dividend yield on Advanced Medical Solutions shares is currently 1.42%.
To buy shares in Advanced Medical Solutions you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 182.60p, shares in Advanced Medical Solutions had a market capitalisation of £398.21m.
Here are the trading details for Advanced Medical Solutions:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: AMS
Based on an overall assessment of its quality, value and momentum Advanced Medical Solutions is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Advanced Medical Solutions is 257.75p. That is 41.16% above the last closing price of 182.60p.
Analysts covering Advanced Medical Solutions currently have a consensus Earnings Per Share (EPS) forecast of £0.12 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Advanced Medical Solutions. Over the past six months, its share price has underperformed the FTSE All Share Index by -12.07%.
As of the last closing price of 182.60p, shares in Advanced Medical Solutions were trading -15.75% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Advanced Medical Solutions PE ratio based on its reported earnings over the past 12 months is 14.4. The shares last closed at 182.60p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Advanced Medical Solutions' management team is headed by:
- Peter Allen - NEC
- Andrew Meredith - CEO
- Eddie Johnson - CFO
- Alan Richardson - COO
- Chris Locke - CTO
- Cathy Tomlinson - DHR
- Simon Coates - OTH
- Rose Guang - OTH
- Ross McDonald - OTH
- Pieter Van-Hoof - OTH
- Becky Walmsley - OTH
- Owen Bromley - SEC
- Grahame Cook - NID
- Penelope Freer - NID
- Douglas Le Fort - NID